Hunan Yiyang Pharmaceutical Co., Ltd.
GPTKB entity
Statements (52)
| Predicate | Object |
|---|---|
| gptkbp:instanceOf |
gptkb:Company
|
| gptkbp:awards |
gptkb:National_Quality_Award
Innovation Award |
| gptkbp:businessModel |
B2B
B2C Wholesale distribution Online sales Contract manufacturing Retail distribution Private label manufacturing |
| gptkbp:CEO |
gptkb:Zhang_Wei
|
| gptkbp:certifications |
GMP_Certification
|
| gptkbp:communityInvolvement |
Health education programs
Charity donations |
| gptkbp:employees |
Over 1000
|
| gptkbp:environmentalInitiatives |
Waste reduction programs
Sustainable_practices |
| gptkbp:exportedTo |
Raw materials
Pharmaceutical products |
| gptkbp:foundedIn |
1998
|
| gptkbp:headquarteredIn |
gptkb:Yiyang,_Hunan,_China
|
| https://www.w3.org/2000/01/rdf-schema#label |
Hunan Yiyang Pharmaceutical Co., Ltd.
|
| gptkbp:investmentFocus |
Infrastructure development
R&D investment Technology upgrades |
| gptkbp:market |
gptkb:China
International markets |
| gptkbp:partnerships |
Various healthcare institutions
|
| gptkbp:productLine |
Antibiotics
Oncology drugs Cardiovascular drugs Analgesics Vitamins and supplements Antipyretics Dermatological drugs Endocrine drugs Gastrointestinal drugs Respiratory drugs Neurology drugs |
| gptkbp:products |
gptkb:Traditional_Chinese_medicine
Injectable drugs Oral drugs |
| gptkbp:regulatoryCompliance |
FDA_regulations
CFDA_regulations |
| gptkbp:researchFocus |
Clinical trials
Drug development |
| gptkbp:researchInterest |
Universities
Research institutes |
| gptkbp:revenue |
Over 500 million RMB
|
| gptkbp:specializesIn |
Pharmaceuticals
|
| gptkbp:subsidiary |
gptkb:Yiyang_Pharmaceutical_Group
|
| gptkbp:website |
www.yiyangpharma.com
|